Effects of Unblocking the Full Potential of Percept PC IPG
Trial
N/A
Completed
Nov. 3, 2024
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Trial
Phase 1
Completed
Oct. 31, 2024
Quest to Analyze One Thousand Humans Meditating
Trial
N/A
Enrolling by invitation
Oct. 31, 2024
The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease
Trial
Phase 1
Recruiting
Oct. 31, 2024
Clinical Trail of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Upper Limb Bradykinesia in Parkinson' Disease' Patients
Trial
N/A
Enrolling by invitation
Oct. 30, 2024
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [Ā¹āøF] AV-133 and DaTscanā¢
Trial
N/A
Active, not recruiting
Oct. 30, 2024
STEPS Trial - Spheramine Safety and Efficacy Study
Trial
Phase 2
Terminated
Oct. 30, 2024
Effectiveness of Oculomotor Training in Parkinson's Disease
Trial
N/A
Completed
Oct. 28, 2024
A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients
Trial
N/A
Completed
Oct. 28, 2024
Somatotopy in Parkinson's Disease
Trial
N/A
Completed
Oct. 25, 2024
Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease
Trial
N/A
Completed
Oct. 23, 2024
Voluntary Activation During Isokinetic Contractions in Subjects with Neuromotor Disorders
Trial
N/A
Recruiting
Oct. 23, 2024
A Proof-of-concept Study Evaluating the Microbiota-gut-brain Axis
Trial
N/A
Recruiting
Oct. 20, 2024
The Effects of Ischemic Conditioning in Individuals with Parkinson's Disease
Trial
N/A
Not yet recruiting
Oct. 17, 2024
Effect of Sensory Electrical Stimulation on Resting Tremors in Patients with Parkinson's Disease
Trial
N/A
Recruiting
Oct. 17, 2024
DTx Algorithms for Personalized Parkinson's Disease Treatment and Medication Plan Optimization
Trial
N/A
Completed
Oct. 16, 2024
Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation
Trial
N/A
Enrolling by invitation
Oct. 15, 2024
Electrophysiological Signature of Mild Cognitive Impairment and Its Relationship with Parkinson's Disease: a High-density EEG Investigation
Trial
N/A
Recruiting
Oct. 14, 2024
Open-Label Extension Study of ASTORIA
Trial
Phase 2
Terminated
Oct. 14, 2024
Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Trial
N/A
Withdrawn
Oct. 14, 2024